Cord Blood Stem and Progenitor Cells

Methods in Enzymology

Volumn 419, Issue , 2006, Pages 439-473

  Broxmeyer, Hal E ^a   Srour, Edward ^a   Orschell, Christie ^a   Ingram, David A ^a   Cooper, Scott ^a   Plett, P Artur ^a   Mead, Laura E ^a   Yoder, Mervin C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW CELL; BURST FORMING UNIT E; CELL ASSAY; CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CELL RENEWAL; COLONY FORMING UNIT GM; COMBINED IMMUNODEFICIENCY; CYTOLOGY; DIABETES MELLITUS; ENDOTHELIUM CELL; EVALUATION; EXPERIMENTAL MODEL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN VITRO STUDY; INFORMATION PROCESSING; LYMPHOID CELL; MEDICAL INFORMATION; METHODOLOGY; MONONUCLEAR CELL; NONHUMAN; OBESITY; PLATING MEDIUM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD;

EID: 33751405576     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)19018-7     Document Type: Chapter

References (92)

1. Aoki M., Yasutake M., and Murohara T. Derivation of functional endothelial progenitor cells from human umbilical card blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 22 (2004) 994-1002
2. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., and Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
3. Barker J.N., Weisdorf D.J., DeFor T.E., Blazar B.R., McGlave P.B., Miller J.S., Verfaillie C.M., and Wagner J.E. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105 (2005) 1343-1347
4. Bock T.A., Orlic D., Dunbar C.E., Broxmeyer H.E., and Bodine D.M. Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes. J. Exp. Med. 182 (1995) 2037-2043
5. Bodine D.M. Animal models for the engraftment and differentiation of human hematopoietic stem and progenitor cells. In: Broxmeyer H.E. (Ed). "Cord Blood: Biology, Immunology, and Clinical Transplantation" (2004), American Association of Blood Banks Press, Bethesda, MD 47-64
6. Bompais H., Chagraoui J., Canron X., Crisan M., Liu X.H., Anjo A., Tolla-Le Port C., Leboeuf M., Charbord P., Bikfalvi A., and Uzan G. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 103 (2004) 2577-2584
7. Breems D.A., Blokland E.A., Neben S., and Ploemacher R.E. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area-forming cell assay. Leukemia 8 (1994) 1095-1104
8. Broxmeyer H.E. Introduction: The past, present, and future of cord blood transplantation. In: Broxmeyer H.E. (Ed). "Cellular Characteristics of Cord Blood and Cord Blood Transplantation" (1998), American Association of Blood Banks Press, Bethesda, MD 1-9
9. Broxmeyer H.E. Cord blood transplantation: Looking back and to the future [introduction]. In: Cohen S.B.A., Gluckman E., Rubinstein P., and Madrigal J.A. (Eds). "Cord Blood Characteristics: Role in Stem Cell Transplantation" (2000), Martin Dunitz, London 1-12
10. Broxmeyer H.E. Proliferation, self-renewal, and survival characteristics of cord blood hematopoietic stem and progenitor cells. In: Broxmeyer H.E. (Ed). "Cord Blood: Biology, Immunology, and Clinical Transplantation" (2004), American Association of Blood Banks Press, Bethesda, MD 1-21
11. Broxmeyer H.E. Biology of cord blood cells and future prospects for enhanced clinical benefit. Cytotherapy 7 (2005) 209-218
12. Broxmeyer H.E., and Cooper S. High efficiency recovery of immature hematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for ten years. Clin. Exp. Immunol. 107 (1997) 45-53
13. Broxmeyer H.E., and Smith F.O. Cord blood hematopoietic cell transplantation. In: Blume K.G., Forman S.J., and Appelbaum F.R. (Eds). "Thomas' Hematopoietic Cell Transplantation". 3rd Ed. (2004), Blackwell Scientific Publications, Cambridge, MA Chapter 43
14. Broxmeyer H.E., Douglas G.W., Hangoc G., Cooper S., Bard J., English D., Arny M., Thomas L., and Boyse E.A. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. USA 86 (1989) 3828-3832
15. Broxmeyer H.E., Gluckman E., Auerbach A., Douglas G.W., Friedman H., Cooper S., Hangoc G., Kurtzberg J., Bard J., and Boyse E.A. Human umbilical cord blood: A clinically useful source of transplantable hematopoietic stem/progenitor cells. Int. J. Cell Cloning 8 (1990) 76-91
16. Broxmeyer H.E., Hangoc G., Cooper S., Ribeiro R.C., Graves V., Yoder M., Wagner J., Vadhan-Raj S., Rubinstein P., and Broun E.R. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation of adults. Proc. Natl. Acad. Sci. USA 89 (1992) 4109-4113
17. Broxmeyer H.E., Srour E.F., Hangoc G., Cooper S., Anderson J.A., and Bodine D. High efficiency recovery of hematopoietic progenitor cells with extensive proliferative and ex-vivo expansion activity and of hematopoietic stem cells with NOD/SCID mouse repopulation ability from human cord blood stored frozen for 15 years. Proc. Natl. Acad. Sci. USA 100 (2003) 645-650
18. + cell engraftment of NOD/SCID mice [abstract 1708]. Blood 106 (2005) 487a
19. - human umbilical cord blood cells reveals their potentiality to engraft adults. Proc. Natl. Acad. Sci. USA 90 (1993) 8707-8711
20. Carow C., Hangoc G., Cooper S., Williams D.E., and Broxmeyer H.E. Mast cell growth factor (c-kit ligand) supports the growth of human multipotential (CFU-GEMM) progenitor cells with a high replating potential. Blood 78 (1991) 2216-2221
21. Carow C.E., Hangoc G., and Broxmeyer H.E. Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: An effect enhanced by cord blood plasma. Blood 81 (1993) 942-949
22. Christopherson II K.W., and Broxmeyer H.E. Hematopoietic stem and progenitor cell homing, engraftment, and mobilization in the context of the CXCL12/SDF-1-CXCR4 axis. In: Broxmeyer H.E. (Ed). "Cord Blood: Biology, Immunology, and Clinical Transplantation" (2004), American Association of Blood Banks Press, Bethesda, MD 65-86
23. Christopherson II K.W., Hangoc G., Mantel C., and Broxmeyer H.E. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305 (2004) 1000-1003
24. Cornetta K., Laughlin M., Carter S., Wall D., Weinthal J., Delaney C., Wagner J., Sweetman R., McCarthy P., and Chao N. Umbilical cord blood transplantation in adults: Results of the prospective cord blood transplantation (COBLT). Biol. Blood Marrow Transpl. 11 (2005) 149-160
25. Crisa L., Cirulli V., Smith K.A., Ellisman M.H., Torbett B.E., and Salomon D.R. Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis. Blood 94 (1999) 3928-3940
26. Denning-Kendall P., Singha S., Bradley B., and Hows J. Cobblestone area-forming cells in human cord blood are heterogeneous and differ from long-term culture-initiating cells. Stem Cells 21 (2003) 694-701
27. Dexter T.M. Synergistic interactions in haematopoiesis: Biological implications and clinical use. Eur. J. Cancer 29A Suppl. (1993) S6-S9
28. Eggermann J., Kliche S., Jarmy G., Hoffmann K., Mayr-Beyrle U., Debatin K.M., Waltenberger J., and Beltinger C. Endothelial progenitor cell culture and differentiation in vitro: A methodological comparison using human umbilical cord blood. Cardiovasc. Res. 58 (2003) 478-486
29. + cells in vitro. Acta Pharmacol. Sin. 24 (2003) 212-218
30. Flamme I., Frolich T., and Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell. Physiol. 173 (1997) 206-210
31. Gan O.I., Murdoch B., Larochelle A., and Dick J.E. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood 90 (1997) 641-650
32. Gluckman E., and Rocha V. History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy 7 (2005) 219-227
33. Gluckman E., Broxmeyer H.E., Auerbach A.D., Friedman H.S., Douglas G.W., Devergie A., Esperou H., Thierry D., Socie G., Lehn P., Cooper S., English D., et al. Hematopoietic reconstitution in a patient with Fanconi anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321 (1989) 1174-1178
34. Gluckman E., Rocha V., Boyer-Chammard A., Locatelli F., Arcese W., Pasquini R., Ortega J., Souillet G., Ferreira E., Laporte J.P., Fernandez M., and Chastang C. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N. Engl. J. Med. 337 (1997) 373-381
35. Gluckman E., Rocha V., Arcese W., Michel G., Sanz G., Chan K.W., Takahashi T.A., Ortega J., Filipovich A., Locatelli F., Asano S., Fagioli F., et al. Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice. Exp. Hematol. 32 (2004) 397-407
36. Gothert J.R., Gustin S.E., van Eekelen J.A., Schmidt U., Hall M.A., Jane S.M., Green A.R., Gottgens B., Izon D.J., and Begley C.G. Genetically tagging endothelial cells in vivo: Bone marrow-derived cells do not contribute to tumor endothelium. Blood 104 (2004) 1769-1777
37. Hao Q.L., Thiemann F.T., Petersen D., Smogorzewska E.M., and Crooks G.M. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood 88 (1996) 3306-3313
38. + progenitors. Blood 104 (2004) 2010-2019
39. Hristov M., and Weber C. Endothelial progenitor cells: Characterization, pathophysiology, and possible clinical relevance. J. Cell. Mol. Med. 8 (2004) 498-508
40. Ingram D., Mead L., Tanaka H., Meade V., Fenoglio A., Mortell K., Pollok K., Ferkowicz M.J., Gilley D., and Yoder M.C. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104 (2004) 2752-2760
41. Iwami Y., Masuda H., and Asahara T. Endothelial progenitor cells: Past, state of the art, and future. J. Cell. Mol. Med. 8 (2004) 488-497
42. Jaroscak J., Goltry K., Smith A., Waters-Pick B., Martin P.L., Driscoll T.A., Howrey R., Chao N., Douville J., Burhop S., Fu P., and Kurtzberg J. Augmentation of umbilical cord blood (UCB) transplantation with ex-vivo-expanded UCB cells: Results of a phase I trial using the AstromReplicell system. Blood 101 (2003) 5061-5067
43. Kamel-Reid S., and Dick J.E. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 242 (1988) 1706-1709
44. + cells. Br. J. Haematol. 113 (2001) 962-969
45. Khakoo A.Y., and Finkel T. Endothelial progenitor cells. Annu. Rev. Med. 56 (2005) 79-101
46. Kurtzberg J., Laughlin M., Graham M.L., Smith C., Olson J.F., Halperin E.C., Ciocci G., Carrier C., Stevens C.E., and Rubinstein P. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated donors. N. Engl. J. Med. 335 (1996) 157-166
47. Kusadasi N., van Soest P.L., Mayen A.E., Koevoet J.L., and Ploemacher R.E. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood. Leukemia 14 (2000) 1944-1953
48. Lansdorp P.M., Dragowska W., and Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J. Exp. Med. 178 (1993) 787-791
49. Lapidot T., Dar A., and Kollet O. How do stem cells find their way home?. Blood 106 (2005) 1901-1910
50. Laughlin M.J., Barker J., Bambach B., Koc O.N., Rizzieri D.A., Wagner J.E., Gerson S.L., Lazarus H.M., Cairo M., Stevens C.E., Rubinstein P., and Kurtzberg. J. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N. Engl. J. Med. 344 (2001) 1815-1822
51. Laughlin M.J., Eapen M., Rubinstein P., Wagner J.E., Zhang M.J., Champlin R.E., Stevens C., Barker J.N., Gale R.P., Lazarus H.M., Marks D.I., van Rood J.J., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N. Engl. J. Med. 351 (2004) 2265-2275
52. Long G.D., Laughlin M., Madan B., Kurtzberg J., Gasparetto C., Morris A., Rizzieri D., Smith C., Vredenburgh J., Halperin E.C., Broadwater G., Niedzwiecki D., et al. Unrelated umbilical cord blood transplantation in adult patients. Biol. Blood Marrow Transplant. 9 (2003) 772-780
53. +++ human umbilical cord blood hematopoietic progenitor cells with high proliferative and replating potential. Blood 81 (1993) 41-48
54. McCune J.M., Namikawa R., Kaneshima H., Shultz L.D., Lieberman M., and Weissman I.L. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function (severe combined immunodeficiency). Science 241 (1988) 1632-1639
55. - progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood 93 (1999) 96-106
56. Murasawa S., and Asahara T. Endothelial progenitor cells for vasculogenesis. Physiology (Bethesda) 20 (2005) 36-42
57. - umbilical cord blood. Stem Cells 22 (2004) 385-395
58. Ooi J., Iseki T., Takahashi S., Tomonari A., Nagayama H., Ishii K., Ito K., Sato H., Takahashi T., Shindo M., Sekine R., Ohno N., et al. A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission. Br. J. Haematol. 118 (2002) 140-143
59. Orazi A., Braun S.E., and Broxmeyer H.E. Immunohistochemistry represents a useful tool to study human cell engraftment in SCID mice transplantation models. Blood Cells 20 (1994) 323-330
60. + cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
61. Peranteau W.H., Endo M., Adibe O.O., Merchant A., Zoltick P., and Flake A.W. CD26 inhibition enhances allogeneic donor cell homing and engraftment after in utero bone marrow transplantation [abstract 1275]. Blood 106 (2005) 371a
62. Pesce M., Orlandi A., Iachininoto M.G., Straino S., Torella A.R., Rizzuti V., Pompilio G., Bonanno G., Scambia G., and Capogrossi M.C. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ. Res. 93 (2003) e51-e62
63. Pettengell R., Luft T., Henschler R., Hows J.M., Dexter T.M., Ryder D., and Testa N.G. Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells. Blood 84 (1994) 3653-3659
64. Ploemacher R.E., van der Sluijs J.P., Voerman J.S., and Brons N.H. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 74 (1989) 2755-2763
65. Ploemacher R.E., van der Sluijs J.P., van Beurden C.A., Baert M.R., and Chan P.L. Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse. Blood 78 (1991) 2527-2533
66. Podesta M., Piaggio G., Pitto A., Zocchi E., Soracco M., Frassoni F., Luchetti S., Painelli E., and Bacigalupo A. Modified in vitro conditions for cord blood-derived long-term culture-initiating cells. Exp. Hematol. 29 (2001) 309-314
67. Punzel M., Wissink S.D., Miller J.S., Moore K.A., Lemischka I.R., and Verfaillie C.M. The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro. Blood 93 (1999) 3750-3756
68. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9 (2003) 702-712
69. Rocha V., Labopin M., Sanz G., Arcese W., Schwerdtfeger R., Bosi A., Jacobsen N., Ruutu T., de Lima M., Finke J., Frassoni F., and Gluckman E. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N. Engl. J. Med. 351 (2004) 2276-2285
70. Rubinstein P., Carrier C., Scaradavou A., Kurtzberg J., Adamson J., Migliaccio A.R., Berkowitz R.L., Cabbad M., Dobrila N.L., Taylor P.E., Rosenfield R.E., and Stevens C.E. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N. Engl. J. Med. 339 (1998) 1565-1577
71. Sanz G.F., Saavedra S., Jimenez C., Senent L., Cervera J., Planelles D., Bolufer P., Larrea L., Martin G., Martinez J., Jarque I., Moscardo F., et al. Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution. Bone Marrow Transplant. 27 (2001) 693-701
72. Sanz G.F., Saavedra S., Planelles D., Senent L., Cervera J., Barragan E., Jimenez C., Larrea L., Martin G., Martinez J., Jarque I., Moscardo F., et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 98 (2001) 2332-2338
73. Schatteman G.C. Adult bone marrow-derived hemangioblasts, endothelial cell progenitors, and EPCs. Curr. Top. Dev. Biol. 64 (2004) 141-180
74. Shaheen M., and Broxmeyer H.E. The humoral regulation of hematopoiesis. In: Hoffman R., Benz E., Shattil S., Furie B., Cohen H., Silberstein L., and McGlave P. (Eds). "Hematology: Basic Principles and Practice". 4th Ed. (2005), Elsevier, Churchill Livingstone, New York 233-265
75. Shpall E.J., Quinones R., Giller R., Zeng C., Baron A.E., Jones R.B., Bearman S.I., Nieto Y., Freed B., Madinger N., Hogan C.J., Slat-Vasquez V., et al. Transplantation of ex-vivo expanded cord blood. Biol. Bone Marrow Transpl. 8 (2002) 368-376
76. Simons M. Angiogenesis: Where do we stand now?. Circulation 111 (2005) 1556-1566
77. Skalak T. Angiogenesis and microvascular remodeling: A brief history and future roadmap. Microcirculation 12 (2005) 47-58
78. Stadtfeld M., and Graf T. Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing. Development 132 (2005) 203
79. Sutherland H.J., Eaves C.J., Eaves A.C., Dragowska W., and Lansdorp P.M. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74 (1989) 1563-1570
80. Takahashi S., Iseki T., Ooi J., Tomonari A., Takasugi K., Shimohakamada Y., Yamada T., Uchimaru K., Tojo A., Shirafuji N., Kodo H., Tani K., et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 104 (2004) 3813-3820
81. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126 (1981) 1614-1619
82. Theunissen K., and Verfaillie C.M. A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay. Exp. Hematol. 33 (2005) 165-172
83. Tian C., Bagley J., Forman D., and Iacomini J. Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther. 13 (2005) 652-658
84. + cells an enhanced ex vivo expansion potential. Exp. Hematol. 22 (1994) 1264-1272
85. Traycoff C.M., Kosak S.T., Grigsby S., and Srour E.F. Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood 85 (1995) 2059-2068
86. Tse W., and Laughlin M.J. Cord blood transplantation in adult patients. Cytotherapy 7 (2005) 228-242
87. Urbich C., and Dimmeler S. Endothelial progenitor cells: Characterization and role in vascular biology. Circ. Res. 95 (2004) 343-353
88. Vormoor J., Lapidot T., Pflumio F., Risdon G., Patterson B., Broxmeyer H.E., and Dick J.E. Immature human cord blood progenitors engraft and proliferate to high levels in immune-deficient SCID mice. Blood 83 (1994) 2489-2497
89. Wagner J.E., Kernan N.A., Steinbuch M., Broxmeyer H.E., and Gluckman E. Allogeneic sibling umbilical cord blood transplantation in forty-four children with malignant and non-malignant disease. Lancet 346 (1995) 214-219
90. Wagner J.E., Rosenthal J., Sweetman R., Shu X.O., Davies S.M., Ramsay N.K., McGlave P.B., Sender L., and Cairo M.S. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease. Blood 88 (1996) 795-802
91. Wagner J.E., Barker J.N., DeFor T.E., Baker K.S., Blazar B.R., Eide C., Goldman A., Kersey J., Krivit W., MacMillan M.L., Orchard P.J., Peters C., et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100 (2002) 1611-1618
92. Weaver A., Ryder W.D., and Testa N.G. Measurement of long-term culture initiating cells (LTC-ICs) using limiting dilution: Comparison of endpoints and stromal support. Exp. Hematol. 25 (1997) 1333-1338